Abbreviated or Standard Antiplatelet Therapy in HBR Patients-Reference-Cited by-同舟云学术

Abbreviated or Standard Antiplatelet Therapy in HBR Patients

Published:2023-04 Issue:7 Volume:16 Page:798-812
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Landi Antonio,Heg Dik,Frigoli Enrico,Vranckx Pascal,Windecker Stephan,Siegrist Patrick,Cayla Guillaume,Włodarczak Adrian,Cook Stephane,Gómez-Blázquez Iván,Feld Yair^ORCID,Seung-Jung Park,Mates Martin,Lotan Chaim,Gunasekaran Sengottuvelu^ORCID,Nanasato Mamoru,Das Rajiv,Kelbæk Henning,Teiger Emmanuel,Escaned Javier,Ishibashi Yuki,Montalescot Gilles,Matsuo Hitoshi,Debeljacki Dragan,Smits Pieter C.^ORCID,Valgimigli Marco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur J Cardiothoracic Surg,2017

2. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease;Levine;J Am Coll Cardiol,2016

3. Bleeding avoidance strategies in percutaneous coronary intervention;Capodanno;Nat Rev Cardiol,2022

4. Ischemic and bleeding risk in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: is it time to REACT?;Valgimigli;Eur Heart J Acute Cardiovasc Care,2021

5. Dual antiplatelet therapy after PCI in patients at high bleeding risk;Valgimigli;N Engl J Med,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative selection bias for women inclusion in a clinical trial;International Journal of Cardiology;2024-08

2. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial;European Journal of Internal Medicine;2024-08

3. Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?;Journal of Cardiology;2024-08

4. Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome;Circulation;2024-07-23

5. Antiplatelet therapy in elderly patients with ACS: moving targets need more tailored treatments;Journal of Thrombosis and Thrombolysis;2024-01-28